2/7/2014 9:11:29 AM
SOUTH SAN FRANCISCO, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced today the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a price of $12.50 per share for an aggregate offering of $37.5 million, before underwriting discounts, commissions and estimated expenses. All of the shares of common stock are being offered by Five Prime. In addition, Five Prime has granted the underwriters a 30-day option to purchase up to 450,000 additional shares of common stock at the offering price. The offering is expected to close on February 12, 2014, subject to customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by